Clinical Trials in Banja Luka, Bosnia and Herzegovina
Locations / Banja Luka, Bosnia and Herzegovina
Delta Trials lists 175 clinical trials conducted in Banja Luka, Bosnia and Herzegovina, making it a notable site of clinical research activity. These trials addressing 154 medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 28 trials in this location have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the Banja Luka research landscape.
175
Total Trials
154
Conditions
28
Terminated since 2020
Browse by condition (154 total)
- Crohn's disease 13 trialsAll Crohn's disease trials
- Rheumatoid arthritis 12 trialsAll Rheumatoid arthritis trials
- Breast cancer 8 trialsAll Breast cancer trials
- Ulcerative colitis 6 trialsAll Ulcerative colitis trials
- Crohn disease 4 trialsAll Crohn disease trials
- Heart failure 4 trialsAll Heart failure trials
- Colitis, ulcerative 4 trialsAll Colitis, ulcerative trials
- Non-small cell lung cancer 4 trialsAll Non-small cell lung cancer trials
- Multiple sclerosis 4 trialsAll Multiple sclerosis trials
- Relapsing multiple sclerosis 3 trialsAll Relapsing multiple sclerosis trials
- Small cell lung cancer 3 trialsAll Small cell lung cancer trials
- Melanoma 3 trialsAll Melanoma trials
- Carcinoma, non-small-cell lung 3 trialsAll Carcinoma, non-small-cell lung trials
- Non-small cell lung cancer stage iv 3 trialsAll Non-small cell lung cancer stage iv trials
- Ulcerative colitis (uc) 3 trialsAll Ulcerative colitis (uc) trials
- Gastroesophageal reflux disease 2 trialsAll Gastroesophageal reflux disease trials
- Sepsis 2 trialsAll Sepsis trials
- Pulmonary arterial hypertension 2 trialsAll Pulmonary arterial hypertension trials
- Neoplasms 2 trialsAll Neoplasms trials
- All Multiple sclerosis, relapsing-remitting trials